LifeMD, Inc. LFMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 44.63M | 47.28M | 50.16M | 46.87M | 47.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.63M | 47.28M | 50.16M | 46.87M | 47.73M |
| Cost of Revenue | 8.25M | 5.28M | 5.93M | 6.03M | 7.06M |
| Gross Profit | 36.38M | 42.00M | 44.24M | 40.84M | 40.67M |
| SG&A Expenses | 35.88M | 44.67M | 48.56M | 37.12M | 39.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.08M | 2.67M | 2.81M | 3.00M | 2.41M |
| Total Operating Expenses | 49.09M | 54.41M | 59.09M | 47.97M | 50.85M |
| Operating Income | -4.47M | -7.13M | -8.93M | -1.10M | -3.13M |
| Income Before Tax | -4.47M | -7.08M | -8.87M | -1.07M | -4.54M |
| Income Tax Expenses | -- | -- | -- | 13.90K | 31.80K |
| Earnings from Continuing Operations | -4.47M | -7.08M | -8.87M | -1.09M | -4.58M |
| Earnings from Discontinued Operations | -- | -- | -- | 21.03M | 935.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 20.70K | -249.50K |
| Net Income | -4.47M | -7.08M | -8.87M | 19.96M | -3.89M |
| EBIT | -4.47M | -7.13M | -8.93M | -1.10M | -3.13M |
| EBITDA | -4.13M | -6.80M | -8.61M | -784.20K | -2.84M |
| EPS Basic | -0.11 | -0.16 | -0.20 | 0.41 | -0.10 |
| Normalized Basic EPS | -0.06 | -0.09 | -0.12 | -0.01 | -0.05 |
| EPS Diluted | -0.11 | -0.16 | -0.20 | 0.41 | -0.10 |
| Normalized Diluted EPS | -0.06 | -0.09 | -0.12 | -0.01 | -0.05 |
| Average Basic Shares Outstanding | 48.18M | 47.79M | 47.34M | 46.77M | 46.16M |
| Average Diluted Shares Outstanding | 48.18M | 47.79M | 47.34M | 46.77M | 46.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -17.37% | -10.96% | -8.75% | 3.89% | -19.97% |